Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹7,125 Cr
down ₹6.4 Cr vs Feb 2024
- Stocks held
- 31
- unchanged
- Top 10 weight
- 60.0%
- of the portfolio in its ten largest
- Cash & debt
- 1.4%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 19
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In March 2024 it disclosed 31 stocks worth ₹7,125 Cr, down ₹6.4 Cr from Feb 2024. Its largest positions were Sun Pharmaceutical Industries Limited (14.9%), Lupin Limited (8.4%), Cipla Limited (6.5%); the ten largest together made up 60.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 79.4% of its equity. Cash and debt stood at 1.4%. Compared with Feb 2024 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
84%
Top-10 weight is higher than 84% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
22%
Holds more cash than 22% of peers
Holdings in March 2024
Download CSVEvery line the fund disclosed, with the change against Feb 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.91%
- Δ weight
- up 0.40 pts
- Value
- ₹1,062 Cr
- Δ value
- up ₹27.9 Cr
- Status
- Added
- Weight
- 8.40%
- Δ weight
- down 0.01 pts
- Value
- ₹599 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Held
- Weight
- 6.51%
- Δ weight
- up 0.08 pts
- Value
- ₹464 Cr
- Δ value
- up ₹5.1 Cr
- Status
- Added
- Weight
- 5.79%
- Δ weight
- up 0.24 pts
- Value
- ₹412 Cr
- Δ value
- up ₹16.6 Cr
- Status
- Added
- Weight
- 4.75%
- Δ weight
- down 0.20 pts
- Value
- ₹339 Cr
- Δ value
- down ₹14.7 Cr
- Status
- Trimmed
- Weight
- 4.40%
- Δ weight
- up 0.19 pts
- Value
- ₹314 Cr
- Δ value
- up ₹13.5 Cr
- Status
- Added
- Weight
- 4.36%
- Δ weight
- down 0.05 pts
- Value
- ₹310 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Weight
- 4.18%
- Δ weight
- up 0.21 pts
- Value
- ₹298 Cr
- Δ value
- up ₹14.9 Cr
- Status
- Added
- Weight
- 3.44%
- Δ weight
- up 0.19 pts
- Value
- ₹245 Cr
- Δ value
- up ₹13.2 Cr
- Status
- Added
- Weight
- 3.29%
- Δ weight
- down 0.16 pts
- Value
- ₹234 Cr
- Δ value
- down ₹11.3 Cr
- Status
- Trimmed
- Weight
- 3.03%
- Δ weight
- up 0.03 pts
- Value
- ₹216 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 2.97%
- Δ weight
- down 0.03 pts
- Value
- ₹212 Cr
- Δ value
- down ₹2.6 Cr
- Status
- Trimmed
- Weight
- 2.91%
- Δ weight
- up 0.21 pts
- Value
- ₹207 Cr
- Δ value
- up ₹14.9 Cr
- Status
- Added
- Weight
- 2.82%
- Δ weight
- down 0.03 pts
- Value
- ₹201 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 2.75%
- Δ weight
- up 0.16 pts
- Value
- ₹196 Cr
- Δ value
- up ₹10.9 Cr
- Status
- Added
- Weight
- 2.70%
- Δ weight
- down 0.19 pts
- Value
- ₹193 Cr
- Δ value
- down ₹14 Cr
- Status
- Trimmed
- Weight
- 2.69%
- Δ weight
- down 0.16 pts
- Value
- ₹191 Cr
- Δ value
- down ₹11.8 Cr
- Status
- Trimmed
- Weight
- 2.62%
- Δ weight
- down 0.10 pts
- Value
- ₹187 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 2.33%
- Δ weight
- down 0.27 pts
- Value
- ₹166 Cr
- Δ value
- down ₹19.4 Cr
- Status
- Trimmed
- Weight
- 2.20%
- Δ weight
- down 0.05 pts
- Value
- ₹157 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 1.87%
- Δ weight
- down 0.18 pts
- Value
- ₹134 Cr
- Δ value
- down ₹13 Cr
- Status
- Trimmed
- Weight
- 1.65%
- Δ weight
- down 0.35 pts
- Value
- ₹118 Cr
- Δ value
- down ₹25.1 Cr
- Status
- Trimmed
- Weight
- 1.46%
- Δ weight
- down 0.25 pts
- Value
- ₹104 Cr
- Δ value
- down ₹17.8 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.44%
- Δ weight
- down 0.62 pts
- Value
- ₹102 Cr
- Δ value
- down ₹44.2 Cr
- Status
- Trimmed
- Reliance Liquid Fund - Treasury Plan- Direct Plan - Growth PlanFund units
- Weight
- 1.41%
- Δ weight
- up 1.41 pts
- Value
- ₹100 Cr
- Δ value
- up ₹100 Cr
- Status
- New
- Weight
- 1.11%
- Δ weight
- down <0.01 pts
- Value
- ₹79 Cr
- Δ value
- down ₹39 L
- Status
- Held
- Weight
- 1.06%
- Δ weight
- down 0.27 pts
- Value
- ₹75.5 Cr
- Δ value
- down ₹19.1 Cr
- Status
- Trimmed
- Weight
- 0.85%
- Δ weight
- down 0.05 pts
- Value
- ₹60.3 Cr
- Δ value
- down ₹3.8 Cr
- Status
- Trimmed
- Weight
- 0.54%
- Δ weight
- down 0.08 pts
- Value
- ₹38.2 Cr
- Δ value
- down ₹5.7 Cr
- Status
- Trimmed
- Weight
- 0.51%
- Δ weight
- up 0.04 pts
- Value
- ₹36 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 0.48%
- Δ weight
- down 0.02 pts
- Value
- ₹34.1 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 0.38%
- Δ weight
- down 0.06 pts
- Value
- ₹26.9 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 0.19%
- Δ weight
- down 0.01 pts
- Value
- ₹13.5 Cr
- Δ value
- down ₹95 L
- Status
- Trimmed
What changed, Feb 2024 to Mar 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹27.9 Cr (+0.40% pts)
- Apollo Hospitals Enterprise Limitedup ₹16.6 Cr (+0.24% pts)
- Zydus Lifesciences Limitedup ₹14.9 Cr (+0.21% pts)
- Mankind Pharma Limitedup ₹14.9 Cr (+0.21% pts)
- Gland Pharma Limited ₹13.5 Cr (+0.19% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.5 pts), and fell most in Healthcare Services (−0.4 pts).
- Pharmaceuticals & Biotechnology78.9% → 79.4%+0.5 pts
- Healthcare Services17.2% → 16.7%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2021 | Mar 2023 | Sep 2023 | Dec 2023 | Feb 2024 | Mar 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.7% | 77.0% | 78.0% | 77.0% | 78.9% | 79.4% |
| Healthcare Services | 17.5% | 19.4% | 16.3% | 18.1% | 17.2% | 16.7% |
| Retailing | — | 1.9% | 4.3% | 3.6% | 3.1% | 3.1% |
| Pharmaceuticals | 2.3% | 1.4% | 1.1% | 1.1% | 0.9% | 0.9% |
Allocation in Mar 2024change vs Feb 2024
- Pharmaceuticals & Biotechnology (21)79.4%▲ 0.5 pts
- Healthcare Services (8)16.7%▼ 0.4 pts
- Retailing (1)3.1%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2024
1.4%
▼ 0.6 pts vs Feb 2024
- Cash alone
- 1.4%
- cash and net receivables
- A year earlier
- 1.2%
- Mar 2023 · now ▲ 0.2 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.